vs
Side-by-side financial comparison of Quipt Home Medical Corp. (QIPT) and STEM, INC. (STEM). Click either name above to swap in a different company.
Quipt Home Medical Corp. is the larger business by last-quarter revenue ($49.0M vs $47.1M, roughly 1.0× STEM, INC.). Quipt Home Medical Corp. runs the higher net margin — -2.1% vs -33.9%, a 31.7% gap on every dollar of revenue. On growth, Quipt Home Medical Corp. posted the faster year-over-year revenue change (32.3% vs -15.6%).
Quipt Home Medical Corp is a U.S.-based home medical equipment provider specializing in respiratory care, sleep therapy supplies, and chronic disease management products. It serves patients with long-term health conditions, partners with healthcare providers and insurance payers across operating regions to deliver accessible in-home medical solutions.
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
QIPT vs STEM — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $49.0M | $47.1M |
| Net Profit | $-1.1M | $-16.0M |
| Gross Margin | 53.5% | 48.9% |
| Operating Margin | 2.1% | -17.7% |
| Net Margin | -2.1% | -33.9% |
| Revenue YoY | 32.3% | -15.6% |
| Net Profit YoY | 2.9% | 68.8% |
| EPS (diluted) | $-0.02 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $49.0M | $47.1M | ||
| Q3 25 | $39.8M | $38.2M | ||
| Q2 25 | $35.1M | $38.4M | ||
| Q1 25 | $33.3M | $32.5M | ||
| Q4 24 | $37.1M | $55.8M | ||
| Q3 24 | — | $29.3M | ||
| Q2 24 | — | $34.0M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | $-1.1M | $-16.0M | ||
| Q3 25 | $-3.5M | $-23.8M | ||
| Q2 25 | $-3.0M | $202.5M | ||
| Q1 25 | $-3.0M | $-25.0M | ||
| Q4 24 | $-1.1M | $-51.1M | ||
| Q3 24 | — | $-148.3M | ||
| Q2 24 | — | $-582.3M | ||
| Q1 24 | — | $-72.3M |
| Q4 25 | 53.5% | 48.9% | ||
| Q3 25 | 48.7% | 35.5% | ||
| Q2 25 | 57.6% | 33.4% | ||
| Q1 25 | 54.6% | 32.4% | ||
| Q4 24 | 52.1% | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | 2.1% | -17.7% | ||
| Q3 25 | -3.6% | -33.6% | ||
| Q2 25 | -5.2% | -34.8% | ||
| Q1 25 | -3.0% | -65.0% | ||
| Q4 24 | 1.2% | -84.4% | ||
| Q3 24 | — | -493.2% | ||
| Q2 24 | — | -1705.5% | ||
| Q1 24 | — | -267.0% |
| Q4 25 | -2.1% | -33.9% | ||
| Q3 25 | -8.9% | -62.2% | ||
| Q2 25 | -8.6% | 527.8% | ||
| Q1 25 | -9.1% | -76.9% | ||
| Q4 24 | -2.9% | -91.6% | ||
| Q3 24 | — | -506.3% | ||
| Q2 24 | — | -1712.6% | ||
| Q1 24 | — | -283.9% |
| Q4 25 | $-0.02 | $-4.40 | ||
| Q3 25 | $-0.07 | $-2.84 | ||
| Q2 25 | $-0.07 | $-1.79 | ||
| Q1 25 | $-0.07 | $-0.15 | ||
| Q4 24 | $-0.03 | $-15.29 | ||
| Q3 24 | — | $-18.24 | ||
| Q2 24 | — | $-71.81 | ||
| Q1 24 | — | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.5M | $48.9M |
| Total DebtLower is stronger | $84.0M | — |
| Stockholders' EquityBook value | $113.0M | $-249.4M |
| Total Assets | $280.7M | $308.9M |
| Debt / EquityLower = less leverage | 0.74× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.5M | $48.9M | ||
| Q3 25 | $12.9M | $43.1M | ||
| Q2 25 | $11.3M | $40.8M | ||
| Q1 25 | $17.1M | $58.6M | ||
| Q4 24 | $15.5M | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | $84.0M | — | ||
| Q3 25 | $87.6M | — | ||
| Q2 25 | $66.0M | — | ||
| Q1 25 | $71.5M | — | ||
| Q4 24 | $70.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $113.0M | $-249.4M | ||
| Q3 25 | $112.1M | $-235.7M | ||
| Q2 25 | $102.5M | $-214.1M | ||
| Q1 25 | $103.6M | $-417.5M | ||
| Q4 24 | $106.3M | $-398.4M | ||
| Q3 24 | — | $-344.1M | ||
| Q2 24 | — | $-203.2M | ||
| Q1 24 | — | $371.6M |
| Q4 25 | $280.7M | $308.9M | ||
| Q3 25 | $283.3M | $362.6M | ||
| Q2 25 | $236.1M | $379.2M | ||
| Q1 25 | $244.6M | $405.1M | ||
| Q4 24 | $242.8M | $437.4M | ||
| Q3 24 | — | $537.8M | ||
| Q2 24 | — | $691.5M | ||
| Q1 24 | — | $1.3B |
| Q4 25 | 0.74× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.64× | — | ||
| Q1 25 | 0.69× | — | ||
| Q4 24 | 0.66× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.9M | $8.2M |
| Free Cash FlowOCF − Capex | $6.9M | — |
| FCF MarginFCF / Revenue | 14.0% | — |
| Capex IntensityCapex / Revenue | 4.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $26.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.9M | $8.2M | ||
| Q3 25 | $9.8M | $11.4M | ||
| Q2 25 | $9.7M | $-21.3M | ||
| Q1 25 | $8.9M | $8.5M | ||
| Q4 24 | $9.3M | $-14.7M | ||
| Q3 24 | — | $-9.4M | ||
| Q2 24 | — | $-11.9M | ||
| Q1 24 | — | $-621.0K |
| Q4 25 | $6.9M | — | ||
| Q3 25 | $8.0M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $7.3M | — | ||
| Q4 24 | $5.6M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 14.0% | — | ||
| Q3 25 | 20.0% | — | ||
| Q2 25 | 12.6% | — | ||
| Q1 25 | 22.0% | — | ||
| Q4 24 | 15.2% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 4.2% | — | ||
| Q3 25 | 4.6% | — | ||
| Q2 25 | 14.9% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
